Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.

Over 11,000 bottles are being pulled from shelves after testing revealed a manufacturing error that introduced trace amounts ...

Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption ...

Glenmark Pharmaceuticals has recalled over eleven thousand bottles of its blood pressure drug Ziac after FDA testing found traces of the cholesterol medication ezetimibe. The Class III recall affects ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

Enhertu (trastuzumab Deruxtecan [T-DXd]) treated patients continue to be eligible for enrollment in FLAMINGO-01. The Company believes that GLSI-100 will synergize with any trastuzumab based treatment ...

Adding lumateperone (Caplyta; Johnson & Johnson) to ongoing antidepressant therapy (ADT) significantly improved depression severity in adults with major depressive disorder (MDD) who had not responded ...

Pet owners are increasingly cognizant of the link between nutrition and pet health, leading to a heightened demand for specialized pet food products. Diseases like obesity, diabetes, and arthritis ...

Wildlife crime is notoriously difficult to prove. For species that take decades to reach maturity, losing even a few adults ...

Confident identification: More fragments are acquired with EAD, allowing users to confidently identify the site of metabolism ...